Claims
- 1. A method for altering the binding characteristics of a DNA-binding protein to a duplex DNA, comprising
- contacting the duplex DNA with a small molecule characterized by sequence-preferential binding to a target region where, when the small molecule is bound to the target region, the small molecule is adjacent to a binding site for the DNA-binding protein and not overlapping the binding site for the DNA-binding protein by more than four basepairs, at a concentration of small molecule effective to alter the binding of the DNA-binding protein to its binding site of the duplex DNA.
- 2. The method of claim 1, where contacting the duplex DNA with the small molecule inhibits the binding of the DNA-binding protein to its binding site.
- 3. The method of claim 1, where contacting the duplex DNA with the small molecule enhances the binding of the DNA-binding protein to its binding site.
- 4. The method of claim 1, where the DNA binding protein is a eucaryotic general transcription factor and the target region is selected from DNA sequences adjacent the binding site for the eucaryotic transcription factor.
- 5. The method of claim 4, where the transcription factor is TFIID.
- 6. The method of claim 5, where the target region is selected from the group of DNA sequences consisting of SEQ ID NO:1 to SEQ ID NO:600.
- 7. The method of claim 1, where the DNA binding protein is a eucaryotic general transcription factor and the small molecule binds, in addition to the target region, 1 to three nucleotide pairs of the DNA-binding protein's binding site.
- 8. The method of claim 7, where the eucaryotic general transcription factor is TFIID, and the small molecule binds to (i) the target region, and (ii) up to two nucleotides of the binding site for the eucaryotic transcription factor, where the nucleotides are contiguous to the target region.
- 9. The method of claim 1, where the DNA binding protein is a DNA replication factor.
- 10. A method for inhibiting the binding of a DNA-binding protein to duplex DNA, comprising
- contacting a compound with a duplex DNA which contains a test sequence adjacent to and not overlapping by more than four basepairs a screening sequence, where the DNA-binding protein binds to the screening sequence in the absence of the compound, where the compound binds to the test sequence without binding to more than four basepairs of said screening sequence, and further where the binding of said compound to the test sequence inhibits the binding of the DNA-binding protein to the screening sequence.
- 11. The method of claim 10, wherein the compound is identified by the steps of
- preparing a series of duplex nucleic acid fragments, each containing a test sequence composed of one of the 4N possible permutations of sequences in a sequence of base pairs having N-basepairs, where said test sequence is adjacent the screening sequence,
- measuring the binding affinity of the DNA binding protein to each of the series of nucleic acid fragments in the presence of the compound, and
- selecting the compound if it lowers the binding affinity of the DNA binding protein for the screening sequence.
- 12. The method of claim 10, wherein said compound binds no more than 1-3 basepairs of said screening sequence.
- 13. The method of claim 10, wherein said compound binds only to said test sequence.
- 14. The method of claim 1, wherein said small molecule binds no more than 1-3 basepairs of said binding site for said DNA-binding protein.
- 15. The method of claim 1, wherein said small molecule binds only to said test sequence.
Parent Case Info
This application is a continuation-in-part of co-owned, co-pending U.S. application Ser. No. 08/123,936, filed Sep. 17, 1993, herein incorporated by reference, which is a continuation-in-part of co-owned, co-pending U.S. application Ser. No. 07/996,783, filed Dec. 23, 1992, herein incorporated by reference, which is a continuation-in-part of co-owned, U.S. application Serial No. 07/723,618, filed Jun. 27, 1991, now abandoned and being prosecuted as co-pending, co-owned, file-wrapper continuation 08/081,070, filed Jun. 22, 1993, now allowed and herein incorporated by reference.
US Referenced Citations (5)
Number |
Name |
Date |
Kind |
4257774 |
Richardson et al. |
Mar 1981 |
|
4270924 |
Crooke et al. |
Jun 1981 |
|
5071773 |
Evans et al. |
Dec 1991 |
|
5096815 |
Ladner et al. |
Mar 1992 |
|
5306619 |
Edwards et al. |
Apr 1994 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
WO8704170 |
Jul 1987 |
WOX |
Non-Patent Literature Citations (7)
Entry |
Ray, R., et al., "Mithramycin Blocks Protein Binding and Function of the SV40 Early Promoter," J. Clin. Invest. 83:2003-2007 (1989). |
Snyder, R. C., et al., "Mithramycin Blocks Transcriptional Initiation of the c-myc P1 and P2 Promoters," Biochemistry 30:4290-4297 (1991). |
Van Dyke, M. W., and Dervan, P. B., "Chromomycin, Mithramycin, and Olivomycin Binding Sites on Heterogeneous Deoxyribonucleic Acid --Footprinting with (Methidiumpropyl-EDTA)ironIII)," Biochemistry 22:2273-2377 (1983). |
Davison, A. J., and Scott, J. E., "The Complete DNA Sequence of Varicella-Zoster Virus," J. Gen. Virol. 67:1759-1816 (1986). |
Hanvey, J. C., et al., "Site-Specific Inhibition of EcoR1 Restriction/Modification Enzymes by a DNA Triple Helix," Nuc. Acids Res. 18(1):157-161 (1990). |
Hobson, K., et al., "Use of DNA-Protein Interaction to Isolate Specific DNA Sequences," Anal. Biochem. 193:220-224 (1991). |
McGeoch, D. J., et al., "The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1," J. Gen. Virol. 69:1531-1574 (1988). |
Continuation in Parts (3)
|
Number |
Date |
Country |
Parent |
123936 |
Sep 1993 |
|
Parent |
996783 |
Dec 1992 |
|
Parent |
723618 |
Jun 1991 |
|